Track topics on Twitter Track topics that are important to you
GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018
Following a Phase IB Trial Demonstrating 100% Disease Control, 86% Objective Response Rate
and 86% R0 & R1 Surgical Resection Rate in All Patients Treated
LAWRENCEVILLE, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE)NEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...